Oppenheimer launched its coverage of Alumis (NASDAQ:ALMS) with an Outperform recommendation and a 12–18-month price target of ...
Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform ...
Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...
We recently compiled a list of the Goldman Sachs’ 35 AI Superstars. In this article, we are going to take a look at where ...
Oppenheimer initiated coverage of Alumis (ALMS) with an Outperform rating and $32 price target The company is focused on delivering ...
Andres Oppenheimer, a columnist for the "Miami Herald," said the Trump administration is targeting illegal immigrants with ...
Christopher Nolan has recently announced his reunion with Oppenheimer star Benny Safdie for his next movie.Safdie, who appeared as physicist Edward Teller in Nolan’s Oscar-winning movie, ...
Fintel on MSN21h
Oppenheimer Upgrades Ovid Therapeutics (OVID)Fintel reports that on January 29, 2025, Oppenheimer upgraded their outlook for Ovid Therapeutics (NasdaqGS:OVID) from ...
Empire on MSN3h
Christopher Nolan’s The Odyssey: Everything We Know So FarThe director of Oppenheimer is preparing to shoot his Ancient Greek epic – with an all-star cast. Read the details at Empire.
Director Christopher Nolan is set to reunite with one of the stars from his multi-award-winning film Oppenheimer for his next movie. The Inception director will follow up his Oscar win with an ...
Peter Oppenheimer, the chief of global equity strategy and the head of macro research for Goldman Sachs in Europe, opined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback